Contracts › W81XWH22C0046
W81XWH22C0046: Award of Cytosorbents Dha Sbir Ph Iii Med R&D Contract for "Integrating Isoagglutinin Reduction for a Universal Dried Plasma Product for Battlefield and First Responder Use"
Awarded to Cytosorbents Medical Inc by Defense Health Agency.
$4.3Mobligated
$4.3Mpotential value
21 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81XWH22C0046 |
|---|---|
| Awardee | Cytosorbents Medical Inc |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 22 August 2022 to 21 December 2026 |
| Potential end | 21 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record